Paper: opening our stem cell collection to the world
In the Ooi lab we have over the years grown our induced pluripotent stem cell (iPSC) portfolio. In 2018 we...
Preclinical Neuroscience
Strengthening fragile synapses.
I develop & test novel treatments in experimental models of schizophrenia, Alzheimer’s Disease and brain tumours, connecting the knowledge from the clinic with my work at the lab bench. To conduct relevant research with long-term impact, I engage with patients, clinicians and government, to understand the needs and options, share my enthusiasm and communicate my work.
In the Ooi lab we have over the years grown our induced pluripotent stem cell (iPSC) portfolio. In 2018 we...
Some progress in my neuropharmacology portfolio of novel treatment options: we have just published our assessment of Liraglutide to combat...
Just weeks after our review on problems with current differentiation protocols, a method for iPSC-derived cholinergic neurons got published in...
Differentiating stem cells into neurons is gaining more and more traction, but is still a very challenging task. We have...
In the Ooi lab we have over the years grown our induced pluripotent stem cell (iPSC) portfolio. In 2018 we...
Some progress in my neuropharmacology portfolio of novel treatment options: we have just published our assessment of Liraglutide to combat...
Episode 1: Let’s start at the beginning, maintaining your iPSC colonies Keeping healthy iPSC colonies, better for clean cultures than...
Growing stem cells and differentiating them into neuronal cells is difficult work. This miniseries has the tips and tricks I...
(C) Martin Engel, 2017